LC vs SPRY · P/E 28, $1.43B cap vs rev $89.1M
LendingClub Corp (LC) versus ARS Pharmaceuticals, Inc (SPRY) — a side-by-side from cached financials, not a winner call.
LendingClub Corp (LC) is a banks - regional company listed on US.
ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
LC does not have a complete income-statement cache yet.
Latest reported SPRY revenue for 2024-12-31 was $89.1M. Net income was $8.0M. Revenue was up 297063.3% from 2023-12-31 to 2024-12-31. SPRY currently screens at market cap $983.1M.
LC currently screens at market cap $1.43B and trailing P/E 28.4. SPRY currently screens at market cap $983.1M.
Not investment advice. Open the LC and SPRY stock pages for the full models.
Not investment advice.